|
BD Brings Immune Assessment-based IVD Assay For COVID-19 Testing
In India The test is conducted on a clinical flow
cytometer which are available with major hospitals and network laboratories
across India.
In a major development, BD (Becton, Dickinson and Company)
has announced the availability of its BD Multitest™ 6-Color TBNK Reagent with BD
Trucount™ Tubes with an expanded clinical application in India, to help identify
COVID-19 patients at increased relative risk of intubation with mechanical
ventilation (IMV) and mortality, in conjunction with clinical findings and the
results of other laboratory testing.
By providing deeper understanding of immune responses,
clinicians can better understand an appropriate course of action for patients
while also prioritizing the use of precious hospital resources.
Speaking on the importance of gauging the patient’s immunity
profile, Pavan Mocherla, Managing Director, BD India/South Asia, says, “As India
continues to battle with this unprecedented healthcare crisis in the wake of the
second wave of COVID-19, application of this immune assessment-based IVD assay
amongst COVID-19 patients could potentially ease out the already choked
healthcare infrastructure in the country by prioritizing hospital admission and
ICU beds to those who are at higher relative risk for requiring ventilator
support, and increased risk of mortality”.
“BD has a long working experience with CD4 Monitoring for HIV
patients through NACO, MOH&FW, Govt of India in the country. We have been
supporting researchers and clinicians to understand immune functions in Cancer,
Primary Immuno Deficiency and COVID-19 Vaccine research as well. We hope that
that availability of this assay kit in India for expanded COVID- 19 clinical
application helps in optimal utilization of hospital resources,” adds Pavan
Mocherla.
The kit, which is approved for use in European Union, has
been reviewed and approved by Drug Controller (General) India CDSCO, India to
monitor the lymphocyte subsets for various applications. The test is conducted
on a clinical flow cytometer which are available with major hospitals and
network laboratories across India. In the current scenario of COVID-19 crisis,
this information can now equip the clinician with a deeper understanding of the
patient’s immune status.
https://www.biospectrumindia.com/news/43/18695/bd-bringsimmune-assessment-based-ivd-assay-for-covid-19-testing-inindia.html
Meril Receives Nod From ICMR For Its
Indigenous COVID-19 Self-test Kit
Synopsis
The company's indigenous home-use rapid antigen test kits 'CoviFind'
will expand access to Covid-19 testing, while also helping the nation meet the
demand for increased and frequent screening to curb the spread of the pandemic,
Meril said in a statement.
Medtech firm Meril on Thursday said it has received approval
from the Indian Council of Medical Research (ICMR) for its selfuse rapid antigen
test kit for Covid-19.
The company's indigenous home-use rapid antigen test kits 'CoviFind'
will expand access to Covid-19 testing, while also helping the nation meet the
demand for increased and frequent screening to curb the spread of the pandemic,
Meril said in a statement.
The test delivers results swiftly, providing accurate results
in 15 minutes, it added.
"By making reliable rapid antigen testing available to all
through a convenient format, Meril's CoviFind test will facilitate early
detection, isolation, treatment and contact tracing," Meril senior
vice-president (Corporate Strategy) Sanjeev Bhatt said.
The test kit is equipped with testing materials including a
test device, one sterile nasal swab and a pre-filled buffer tube with a cap and
is priced at Rs 250 as an affordable single-pack, the company said.
The test kits will be available in two weeks at retail
pharmacies, epharmacies and through e-commerce platforms including Amazon and
Flipkart, it added.
Meril said it has also supplied a large number of tests
across its Covid-19 diagnostics offerings across India, which include a
multiplex RT-PCR test, Kavach antibody tests in partnership with ICMR.
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/meril-receives-nod-from-icmr-for-its-indigenouscovid-19-self-test-kit/articleshow/83400008.cms |
